• Abad-Lacruz A, Fernandez-Banares F, Cabre E, Gil A, Esteve M, Gonzalez-Huix F, Xiol X, Gassull MA. The effect of total enteral tube feeding on the vitamin status of malnourished patients with inflammatory bowel disease. Int. J. Vitam. Nutr. Res. 58: 428-435 (1988).

• Adachi Y, Nanno T, Itoh T, Kurumi Y, Yamazaki K, Sawada Y, Yamamoto T. Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test. Gastroenterol. Jpn. 23: 401-407 (1988).

• al-Hussami O, Godinot C, Monier JM, Trepo C, Monier JC. Use of immunoblotting to characterize the mitochondrial antigens recognized by anti-mitochondrial autoantibodies. J. Immunol. Methods 113: 61-73 (1988).

• Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig. Dis. Sci. 33: 1223-1225 (1988).

• Amedee-Manesme O, Mourey MS, Therasse J, Couturier M, Alvarez F, Hanck A, Bernard O. Short- and long-term vitamin A treatment in children with cholestasis. Am. J. Clin. Nutr. 47: 690-693 (1988). *

• Ament ME, Berquist W, Vargas J. Advances in ulcerative colitis. Pediatrician 15: 45-57 (1988).

• Anderson CS, Nicholls J, Rowland R, LaBrooy JT. Hepatic granulomas: a 15-year experience in the Royal Adelaide Hospital. Med. J. Aust. 148: 71-74 (1988).

• Andree H. Primary biliary cirrhosis. Z. Arztl. Fortbild. (Jena) 82: 255-263 (1988).

• Aparicio-Pages MN, Verspaget HW, Pena AS, Weterman IT, Mieremet-Ooms MA, van der Zon JM, de Bruin PA, Lamers CB. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis. J. Clin. Lab. Immunol. 27: 109-113 (1988).

• Aprosina ZG, Lopatkina TN, Iakovenko EP, Krel' PE, Saiapina ES. Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus. Ter. Arkh. 60: 23-28 (1988).

• Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 43: 84-92 (1988). *

• Arveiler B, Petkovich M, Mandel JL, Chambon P. A PstI RFLP for the human retinoic acid receptor in 17q21. Nucleic Acids Res. 16: 6252 (1988). *

• Ayalon A, Wiesner RH, Perkins JD, Tominaga S, Hayes DH, Krom RA. Splenic artery aneurysms in liver transplant patients. Transplantation 45: 386-389 (1988).

• Babb RR. The use of metronidazole (Flagyl) in Crohn's disease. J. Clin. Gastroenterol. 10: 479-481 (1988).

• Badr-el-Din S, Trejdosiewicz LK, Heatley RV, Losowsky MS. Local immunity in ulcerative colitis: evidence for defective secretory IgA production. Gut 29: 1070-1075 (1988). *

• Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. U.S.A. 85: 3294-3298 (1988). *

• Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 95: 1395-1398 (1988).

• Baldo-Enzi G, Baiocchi MR, Grotto M, Floreani AR, Zagolin M, Chiaramonte M, Cera F, Fellin R. Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects. Dig. Dis. Sci. 33: 1201-1207 (1988).

• Bartmann P, Fleischer S, Wagner H, Kleihauer E. IgG subclass deficiency in childhood. Changes in the antigen specific immune response and significance of low IgG4 level. Monatsschr. Kinderheilkd. 136: 31-37 (1988).

• Baxter PS, Dickson JA, Variend S, Taylor CJ. Intestinal disease in cystic fibrosis. Arch. Dis. Child. 63: 1496-1497 (1988). *

• Bayerdorffer E, Bock H. Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease. Leber. Magen. Darm. 18: 104-113 (1988).

• Bell KM, Plon L, Bunney WE Jr, Potkin SG. S-Adenosylmethionine treatment of depression: a controlled clinical trial. Am. J. Psychiatry 145: 1110-1114 (1988).

• Benson EB, Strober W. Regulation of IgA secretion by T cell clones derived from the human gastrointestinal tract. J. Immunol. 140: 1874-1882 (1988).

• Berg PA, Klein R. Therapy of primary biliary cirrhosis. Dtsch. Med. Wochenschr. 113: 145-148 (1988).

• Berg PA, Klein R. Diagnosis of primary biliary cirrhosis. Dtsch. Med. Wochenschr. 113: 143-145 (1988).

• Berg PA, Klein R. Molecular determination of the primary biliary cirrhosis-specific M2 antigen. Hepatology 8: 200-201 (1988).

• Bhat PV, Poissant L, Falardeau P, Lacroix A. Enzymatic oxidation of all-trans retinal to retinoic acid in rat tissues. Biochem. Cell. Biol. 66: 735-740 (1988).

• Bilhartz LE. Cholesterol gallstone disease: the current status of nonsurgical therapy. Am. J. Med. Sci. 296: 45-56 (1988).

• Billiar TR, Maddaus MA, West MA, Curran RD, Wells CA, Simmons RL. Intestinal Gram-negative bacterial overgrowth in vivo augments the in vitro response of Kupffer cells to endotoxin. Ann. Surg. 208: 532-540 (1988). *

• Bircher AJ, Meier-Ruge W. Aquagenic pruritus. Water-induced activation of acetylcholinesterase. Arch. Dermatol. 124: 84-89 (1988).

• Bird P, Calvert JE, Mitchison H, Ling NR, Bassendine M, James OF. Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture. Clin. Exp. Immunol. 71: 475-480 (1988). *

• Blanc D, Zultak M, Wendling D, Lonchampt F. Eruptive pyogenic granulomas and acne fulminans in two siblings treated with isotretinoin. A possible common pathogenesis. Dermatologica 177: 16-18 (1988).

• Blomhoff R, Berg T, Norum KR. Transfer of retinol from parenchymal to stellate cells in liver is mediated by retinol-binding protein. Proc. Natl. Acad. Sci. U.S.A. 85: 3455-3458 (1988). *

• Boraz RA. Oral manifestations of Crohn disease: update of the literature and report of case. ASDC J. Dent. Child. 55: 72-74 (1988).

• Braganza JM. The role of the liver in exocrine pancreatic disease. Int. J. Pancreatol. 3 Suppl. 1: S19-42 (1988).

• Brand N, Petkovich M, Krust A, Chambon P, de The H, Marchio A, Tiollais P, Dejean A. Identification of a second human retinoic acid receptor. Nature 332: 850-853 (1988). *

• Brandt DJ, MacCarty RL, Charboneau JW, LaRusso NF, Wiesner RH, Ludwig J. Gallbladder disease in patients with primary sclerosing cholangitis. AJR Am. J. Roentgenol. 150: 571-574 (1988). *

• Brantley SG, Jaffe R, Esquivel CO, Ramsey G. Acute humoral rejection of an ABO-unmatched liver allograft in a pediatric recipient. Pediatr. Pathol. 8: 467-475 (1988).

• Brinson RR, Curtis WD, Schuman BM, Mills LR. Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis. Dig. Dis. Sci. 33: 1615-1620 (1988).

• Brock DJ, Clarke HA, Barron L. Prenatal diagnosis of cystic fibrosis by microvillar enzyme assay on a sequence of 258 pregnancies. Hum. Genet. 78: 271-275 (1988).

• Bugawan TL, Horn GT, Long CM, Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J. Immunol. 141: 4024-4030 (1988).

• Bulger K, Griffin M, Dervan P, Lennon J, Crowe J. Coeliac disease in association with inflammatory bowel disease. Postgrad. Med. J. 64: 336 (1988). *

• Burke DA, Axon AT. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ 297: 102-104 (1988). *

• Burke DA, Axon AT. Hydrophobic adhesin of E. coli in ulcerative colitis. Gut 29: 41-43 (1988). *

• Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J. Am. Optom. Assoc. 59: 221-224 (1988).

• Canivet B, Archambeaud F. Pyrithioxine and hypoglycemic autoimmune syndrome. Autoimmunity 1: 321-322 (1988).

• Carnicer Jauregui F, Casellas Valde JA, Sanchez-Cuenca J, Gomez Andres A. Hepatocarcinoma in primary biliary cirrhosis. Rev. Esp. Enferm. Apar. Dig. 74: 578-579 (1988).

• Castell JV, Larrauri A, Gomez-Lechon MJ. A study of the relative hepatotoxicity in vitro of the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and butibufen. Xenobiotica 18: 737-745 (1988).

• Ceri H, Falkenberg-Anderson K, Fang RX, Costerton JW, Howard B, Banwell JG. Bacteria-lectin interactions in phytohemagglutinin-induced bacterial overgrowth of the small intestine. Can. J. Microbiol. 34: 1003-1008 (1988).

• Chan T, Palevsky HI, Miller WT. Pulmonary hypertension complicating portal hypertension: findings on chest radiographs. AJR Am. J. Roentgenol. 151: 909-914 (1988). *

• Chapman RW, Kelly PM, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29: 422-427 (1988). *

• Chatzinoff M, Guarino JM, Corson SL, Batzer FR, Friedman LS. Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig. Dis. Sci. 33: 108-110 (1988).

• Chevailler A, Saint-Andre JP, Preel JL, Boyer J, Joubaud F, Hurez D. Clinico-immunological profile of hepatic and extrahepatic diseases accompanied by anti-mitochondrial antibodies. Ann. Med. Interne. (Paris) 139: 19-23 (1988).

• Chong RS, Ng HS, Seah CS. Primary biliary cirrhosis: a description of four cases. Singapore Med. J. 29: 68-71 (1988).

• Claman P. Sulfasalazine and male infertility. CMAJ 138: 99-100 (1988). *

• Connolly AK, Price SC, Connelly JC, Hinton RH. Early changes in bile duct lining cells and hepatocytes in rats treated with alpha-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 93: 208-219 (1988).

• Cooper JF, Brand EJ. Symptomatic sclerosing cholangitis in patients with a normal alkaline phosphatase: two case reports and a review of the literature. Am. J. Gastroenterol. 83: 308-311 (1988).

• Coppel RL, McNeilage LJ, Surh CD, Van de Water J, Spithill TW, Whittingham S, Gershwin ME. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc. Natl. Acad. Sci. U.S.A. 85: 7317-7321 (1988). *

• Cowchock S, Fort J, Munoz S, Norberg R, Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin. Exp. Immunol. 73: 289-294 (1988). *

• Cravetto C, Molino G, Hofmann AF, Belforte G, Bona B. Computer simulation of portal venous shunting and other isolated hepatobiliary defects of the enterohepatic circulation of bile acids using a physiological pharmacokinetic model. Hepatology 8: 866-878 (1988).

• Cynamon HA, Norcross K, Isenberg JN. Evoked potential abnormalities in children with chronic cholestasis. Hepatology 8: 1596-1601 (1988).

• Czaja AJ. Diagnosis and management of chronic active hepatitis B. Compr. Ther. 14: 46-53 (1988).

• Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95: 448-453 (1988).

• Czaja AJ, Shiels MT, Taswell HF, Wood JR, Ludwig J, Chase RC. Frequency and significance of immunoglobulin M antibody to hepatitis B core antigen in corticosteroid-treated severe chronic active hepatitis B. Mayo Clin. Proc. 63: 119-125 (1988).

• Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch. Intern. Med. 148: 297-302 (1988).

• Davis BH, Vucic A. The effect of retinol on Ito cell proliferation in vitro. Hepatology 8: 788-793 (1988).

• Delvenne P, Mazy V, Borlon A, Schurgers P, Loly J, Boniver J, Focan C. Sclerosing cholangitis: review of the literature apropos of a case. Rev. Med. Liege. 43: 563-568 (1988).

• Derhaag PJ, Linssen A, Broekema N, de Waal LP, Feltkamp TE. A familial study of the inheritance of HLA-B27-positive acute anterior uveitis. Am. J. Ophthalmol. 105: 603-606 (1988).

• Deschamps I, Marcelli-Barge A, Lallemand N, Poirier JC, Bochu V, Prevost P, Busson A, Masset M, Lestradet H, Hors J. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Tissue Antigens 31: 259-269 (1988).

• DiBenedetto MJ, Napolitana GT, Steigbigel RT. Recurrent toxic shock syndrome in a man: possible role of IgA deficiency. Am. J. Med. 85: 564-566 (1988).

• Domar U, Danielsson A, Hirano K, Stigbrand T. Alkaline phosphatase isozymes in non-malignant intestinal and hepatic diseases. Scand. J. Gastroenterol. 23: 793-800 (1988).

• Dowsett JF, Miller R, Davidson R, Vaira D, Polydorou A, Cairns SR, Weller IV. Sclerosing cholangitis in acquired immunodeficiency syndrome. Case reports and review of the literature. Scand. J. Gastroenterol. 23: 1267-1274 (1988).

• Durand JP, el-Zaatari FA, Krieg AM, Taurog JD. Restriction fragment length polymorphism of T cell receptor alpha and beta chain genes in patients with ankylosing spondylitis. J. Rheumatol. 15: 1115-1158 (1988).

• Enders GA, Ballhaus S, Brendel W. The influence of Peyer's patches on the organ-specific distribution of IgA plasma cells. Immunology 63: 411-414 (1988). *

• Epstein O. Primary biliary cirrhosis and the CREST syndrome: new terminology? Hepatology 8: 189 (1988).

• Epstein O. Review: the treatment of primary biliary cirrhosis. Aliment. Pharmacol. Ther. 2: 1-12 (1988).

• Esquivel CO, Marsh JW, Van Thiel DH. Liver transplantation for chronic cholestatic liver disease in adults and children. Gastroenterol. Clin. North Am. 17: 145-155 (1988).

• Everson GT, Fennessey P, Kern F Jr. Contraceptive steroids alter the steady-state kinetics of bile acids. J. Lipid Res. 29: 68-76 (1988). *

• Ewe K, Eckardt V, Kanzler G. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects. Scand. J. Gastroenterol. Suppl. 148: 70-75 (1988).

• Fardy JM, Lloyd DA, Reynolds RP. Adverse effects with oral 5-aminosalicyclic acid. J. Clin. Gastroenterol. 10: 635-637 (1988).

• Feldman L, Venta L. Percutaneous cholecystostomy of an ectopic gallbladder. Gastrointest. Radiol. 13: 256-258 (1988).

• Fernandez N, Hitman GA, Festenstein H, Garde L, Labeta M, Walker-Smith JA, Sachs JA. Novel HLA class II-associated structural patterns in coeliac disease and type I diabetes. Clin. Exp. Immunol. 72: 362-366 (1988). *

• Fich A, Eliakim R. Does sulfasalazine induce alopecia? J. Clin. Gastroenterol. 10: 466 (1988).

• Fleig WE, Laudage G, Sommer H, Wellmann W, Stange EF, Riemann J. Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis. Digestion 40: 173-180 (1988).

• Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia 31: 864-870 (1988).

• Font J, Bosch X, Ferrer J, Perez-Villa F, Ingelmo M. Systemic lupus erythematosus and ulcerative colitis. Lancet 1: 770 (1988).

• Fregeau DR, Leung PS, Coppel RL, McNeilage LJ, Medsger TA Jr, Gershwin ME. Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum. 31: 386-392 (1988).

• Fronek Z, Timmerman LA, Alper CA, Hahn BH, Kalunian K, Peterlin BM, McDevitt HO. Major histocompatibility complex associations with systemic lupus erythematosus. Am. J. Med. 85: 42-44 (1988).

• Fusconi M, Ghadiminejad I, Bianchi FB, Baum H, Bottazzo GF, Pisi E. Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay. Gut 29: 440-447 (1988). *

• Fussey SP, Guest JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc. Natl. Acad. Sci. U.S.A. 85: 8654-8658 (1988). *

• Gagnerie F, Taillan B, Euller-Ziegler L, Ziegler G. Primary biliary cirrhosis, temporal arteritis (giant cell arteritis) and polymyalgia rheumatica in a single patient. Scand. J. Rheumatol. 17: 231-232 (1988).

• Gambella GR, Bellotti S, Vascotto E, Novelli A. Biochemical changes in the liver of the rat after ligation of the common bile duct. Pathologica 80: 97-103 (1988).

• Gao XJ, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F, Stastny P. Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am. J. Med. 85: 14-16 (1988).

• Garthright WE, Archer DL, Kvenberg JE. Estimates of incidence and costs of intestinal infectious diseases in the United States. Public Health Rep. 103: 107-115 (1988).

• Garza Trasobares E, Suarez Parga JM, Gonzalez Sanz-Agero P, Villeta Caraballo E, Lamas Lorenzo M. Primary sclerosing cholangitis and adenocarcinoma of the colon. Complications in a case of ulcerative colitis. Rev. Esp. Enferm. Apar. Dig. 74: 373-375 (1988).

• Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, Kan AE, Brown JM, Dorney SF. Liver disease and common-bile-duct stenosis in cystic fibrosis. N. Engl. J. Med. 318: 340-346 (1988).

• Geboes K, Rutgeerts P, Penninckx F, Desmet V, Vantrappen G. Changes in small intestinal epithelial expression of MHC class II antigen after terminal ileal resection for Crohn's disease. Int. J. Colorectal Dis. 3: 102-108 (1988).

• Gentile S, Persico M, Orlando C, Le Grazie C, Di Padova C, Coltorti M. Effect of different doses of S-adenosyl-L-methionine (SAMe) on nicotinic acid-induced hyperbilirubinaemia in Gilbert's syndrome. Scand. J. Clin. Lab. Invest. 48: 525-529 (1988).

• Gershwin ME, Coppel RL, Mackay IR. Primary biliary cirrhosis and mitochondrial autoantigens - insights from molecular biology. Hepatology 8: 147-151 (1988).

• Geubel AP, Mairlot MC, Buchet JP, Dive C, Lauwerys R. Abnormal methylation capacity in human liver cirrhosis. Int. J. Clin. Pharmacol. Res. 8: 117-122 (1988).

• Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 94: 488-493 (1988).

• Gilbert J, Kelleher J, Littlewood JM, Evans DF. Ileal pH in cystic fibrosis. Scand. J. Gastroenterol. Suppl. 143: 132-134 (1988). *

• Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, Torres M, Humbert P, Rimola A, Llach J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 94: 1493-1502 (1988).

• Gony J, Vexiau P, Lhomme C, Marcelli A, Poirier JC, Bochu V, Cathelineau G, Assan R, Deschamps I, Hors J. MHC classes I, II, III antigens study in 70 insulin-dependent diabetics with associated auto-immune diseases. Tissue Antigens 31: 229-234 (1988).

• Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, Gay R. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94: 257-265 (1988).

• Graham SM, Barwick K, Cahow CE, Baker CC. Cholangitis glandularis proliferans. A histologic variant of primary sclerosing cholangitis with distinctive clinical and pathological features. J. Clin. Gastroenterol. 10: 579-583 (1988).

• Gravallese EM, Kantrowitz FG. Arthritic manifestations of inflammatory bowel disease. Am. J. Gastroenterol. 83: 703-709 (1988).

• Greenbaum LA, Horowitz JB, Woods A, Pasqualini T, Reich EP, Bottomly K. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells. J. Immunol. 140: 1555-1560 (1988).

• Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 29: 588-592 (1988). *

• Grennan DM, Sanders PA. Rheumatoid arthritis. Baillieres Clin. Rheumatol. 2: 585-601 (1988).

• Grippon P, Cadranel JF, Opolon P. Primary biliary cirrhosis. Rev. Med. Interne. 9: 501-506 (1988).

• Grungreiff K, Abicht K, Kluge M, Presser HJ, Franke D, Kleine FD, Klauck S, Diete U. Clinical studies on zinc in chronic liver diseases. Z. Gastroenterol. 26: 409-415 (1988).

• Gugenheim J, Ciardullo M, Traynor O, Bismuth H. Bronchobiliary fistulas in adults. Ann. Surg. 207: 90-94 (1988). *

• Haag K, Strittmatter B, Glatt E, Hellerich U, Lausen M, Ruckauer KD. Space occupying lesion in the area of the portal vein and obstructive jaundice. Med. Klin. (Munich) 83: 678-681 (1988).

• Habal FM, Greenberg GR. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Am. J. Gastroenterol. 83: 15-19 (1988).

• Haboubi NY, Asquith P. Gastric angiodysplasia associated with primary biliary cirrhosis. Lancet 2: 972 (1988).

• Hadjis NS, Adam A, Hatzis G, Blenkharn I, Thompson IW, Blumgart LH. Primary sclerosing cholangitis: symptomatic and cholangiographic improvement after peripheral drainage. Am. J. Gastroenterol. 83: 312-315 (1988).

• Hall R, Kok E, Javitt NB. Bile acid synthesis: down-regulation by monohydroxy bile acids. FASEB J. 2: 152-156 (1988). *

• Hansen BU, Lindgren S, Eriksson S, Henricsson V, Larsson A, Manthorpe R, Warfvinge G. Clinical and immunological features of Sjogren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med. Scand. 224: 611-619 (1988).

• Hashida Y, Yunis EJ. Syndromatic paucity of interlobular bile ducts: hepatic histopathology of the early and endstage liver. Pediatr. Pathol. 8: 1-15 (1988).

• Hasselstrom K, Nilsson LA, Wallerstedt S. The predictive value of antimitochondrial antibodies in establishing the diagnosis of primary biliary cirrhosis. Scand. J. Gastroenterol. 23: 103-106 (1988).

• Haug K, Schrumpf E, Barstad S, Fluge G, Halvorsen JF. Epidemiology of ulcerative colitis in Western Norway. Scand. J. Gastroenterol. 23: 517-522 (1988).

• Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA, Baker AR, Shine J, McDonnell DP, Hughes M, et al. Molecular biology of the vitamin D hormone. Recent Prog. Horm. Res. 44: 263-305 (1988).

• Hawrylak K, Stinson RA. The solubilization of tetrameric alkaline phosphatase from human liver and its conversion into various forms by phosphatidylinositol phospholipase C or proteolysis. J. Biol. Chem. 263: 14368-14373 (1988). *

• Hay JE, Wiesner RH, Shorter RG, LaRusso NF, Baldus WP. Primary sclerosing cholangitis and celiac disease. A novel association. Ann. Intern. Med. 109: 713-717 (1988).

• Hedenborg G, Jonsson G, Norman A, Wisen O. Bile constituents in ascitic fluid. Scand. J. Clin. Lab. Invest. 48: 543-552 (1988).

• Heikkinen J, Ronnberg L, Kirkinen P, Sotaniemi E. Serum bile acid concentrations as an indicator of liver dysfunction induced during danazol therapy. Fertil. Steril. 50: 761-765 (1988).

• Hein J, Schober S, Seyfarth M, Brock J, Kirschnick HD. Secretory immunoglobulin A (sIgA) in the serum of cystic fibrosis patients. Wien. Klin. Wochenschr. 100: 57-59 (1988).

• Henthorn PS, Raducha M, Kadesch T, Weiss MJ, Harris H. Sequence and characterization of the human intestinal alkaline phosphatase gene. J. Biol. Chem. 263: 12011-12019 (1988). *

• Hermann E, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH. Rheumatologic syndrome in gastrointestinal diseases. Clinical and pathogenetic aspects. Z. Gastroenterol. 26: 137-144 (1988).

• Heuman DM, Vlahcevic ZR, Bailey ML, Hylemon PB. Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat. Hepatology 8: 892-897 (1988).

• Hirakata M, Akizuki M, Miyachi K, Matsushima H, Okano T, Homma M. Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases. J. Rheumatol. 15: 1166-1170 (1988).

• Ho F, Snape WJ Jr, Venegas R, Lechago J, Klein S. Choledochal fungal ball. An unusual cause of biliary obstruction. Dig. Dis. Sci. 33: 1030-1034 (1988).

• Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 94: 1006-1013 (1988).

• Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc. Natl. Acad. Sci. U.S.A. 85: 6012-6016 (1988). *

• Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum. Immunol. 21: 249-263 (1988).

• Horvat Z, Markeljevic J, Cikes N, Cukusic I. Report of a female patient with progressive systemic sclerosis and primary biliary cirrhosis. Lijec. Vjesn. 110: 21-24 (1988).

• Howell MD, Smith JR, Austin RK, Kelleher D, Nepom GT, Volk B, Kagnoff MF. An extended HLA-D region haplotype associated with celiac disease. Proc. Natl. Acad. Sci. U.S.A. 85: 222-226 (1988). *

• Humbert P, Dupond JL. Multiple autoimmune syndromes. Ann. Med. Interne. (Paris) 139: 159-168 (1988).

• Illingworth DR. An overview of lipid-lowering drugs. Drugs 36 Suppl. 3: 63-71 (1988).

• in't Veld G, Mannion B, Weiss J, Elsbach P. Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles. Infect. Immun. 56: 1203-1208 (1988). *

• Innes GK, Nagafuchi Y, Fuller BJ, Hobbs KE. Increased expression of major histocompatibility antigens in the liver as a result of cholestasis. Transplantation 45: 749-752 (1988).

• Ireland A, Mason CH, Jewell DP. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. Gut 29: 835-837 (1988). *

• Isseroff RR. Fish again for dinner! The role of fish and other dietary oils in the therapy of skin disease. J. Am. Acad. Dermatol. 19: 1073-1080 (1988).

• Jackson R, McNicol AM, Farquharson M, Foulis AK. Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison's disease. J. Pathol. 155: 113-120 (1988).

• James SP. Cellular immune mechanisms in the pathogenesis of Crohn's disease. In Vivo 2: 1-7 (1988).

• Jewell DP, Ireland A. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis. Scand. J. Gastroenterol. Suppl. 148: 45-47 (1988).

• Jorge A, Findor J, Esley C, Bruch E. Primary sclerosing cholangitis. Z. Gastroenterol. 26: 322-330 (1988).

• Kaplan MM, Elta GH, Furie B, Sadowski JA, Russell RM. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology 95: 787-792 (1988).

• Kaplan MM, Knox TA, Arora S. Primary biliary cirrhosis (PBC): is effective therapy now at hand? Trans. Assoc. Am. Physicians 101: 193-202 (1988).

• Kawanishi H, Mirabella S. Regulation of mucosal IgA production in vitro by autoreactive immunoregulatory T cells from murine Peyer's patches. Cell. Immunol. 114: 324-335 (1988). *

• Keeffe EB, Lieberman DA, Krishnamurthy S, Krishnamurthy GT, Gilbert SA. Primary biliary cirrhosis: Tc-99m IDA planar and SPECT scanning. Radiology 166: 143-148 (1988).

• Kemp CM, Jacobson SG, Faulkner DJ, Walt RW. Visual function and rhodopsin levels in humans with vitamin A deficiency. Exp. Eye Res. 46: 185-197 (1988).

• Kirschner BS. Inflammatory bowel disease in children. Pediatr. Clin. North Am. 35: 189-208 (1988).

• Klein R, Berg PA. Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis. Dtsch. Med. Wochenschr. 113: 1549-1553 (1988).

• Klein R, Berg PA. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin. Exp. Immunol. 74: 68-74 (1988). *

• Klein R, Kloppel G, Fischer R, Fintelmann V, Muting D, Berg PA. The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis. J. Hepatol. 6: 299-306 (1988).

• Klemola T, Savilahti E, Koskimies S. Transient IgA and IgM deficiencies are frequent in children with ulcerative colitis. Eur. J. Pediatr. 147: 184-187 (1988).

• Klemola T, Savilahti E, Koskimies S, Pelkonen P. HLA antigens in IgA deficient paediatric patients. Tissue Antigens 32: 218-223 (1988).

• Kraut RA, Kessler HP. Management of chronic sclerosing sialadenitis incident to second-stage implant surgery. Compendium 9: 610, 612, 614-615 (1988).

• Krishnamurthy S, Krishnamurthy GT, Lieberman D, Keeffe EB. Scintigraphic criteria for the diagnosis of obstructive hepatobiliary diseases with Tc-99m IDA. Clin. Nucl. Med. 13: 704-709 (1988).

• Kurtz WJ, Guldutuna S, Leuschner U. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents. Tokai. J. Exp. Clin. Med. 13: 91-97 (1988).

• Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Ho M. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 67: 132-143 (1988).

• Lake JR, Renner EL, Scharschmidt BF, Cragoe EJ Jr, Hagey LR, Lambert KJ, Gurantz D, Hofmann AF. Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation. Gastroenterology 95: 454-463 (1988).

• Lakhanpal S, O'Duffy JD, Homburger HA, Moore SB. Evidence for linkage of IgA deficiency with the major histocompatibility complex. Mayo Clin. Proc. 63: 461-465 (1988).

• Lamy P, Valla D, Bourgeois P, Rueff B, Benhamou JP. Primary sclerosing cholangitis and systemic lupus erythematosus. Gastroenterol. Clin. Biol. 12: 962-964 (1988).

• Larrey D, Erlinger S. Drug-induced cholestasis. Baillieres Clin. Gastroenterol. 2: 423-452 (1988).

• Larrey D, Freneaux E, Berson A, Babany G, Degott C, Valla D, Pessayre D, Benhamou JP. Peliosis hepatis induced by 6-thioguanine administration. Gut 29: 1265-1269 (1988). *

• LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 95: 1036-1042 (1988).

• Lassoued K, Guilly MN, Andre C, Paintrand M, Dhumeaux D, Danon F, Brouet JC, Courvalin JC. Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin. Exp. Immunol. 74: 283-288 (1988). *

• Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment. Gut 29: 1316-1321 (1988). *

• Lauschke G, Schmiedel T, Franke WG, Frenzel S. Results of functional scintigraphic studies of the hepatobiliary system following reconstruction of bile duct injuries with ring drainage splinting. Zentralbl. Chir. 113: 1175-1184 (1988).

• Lerut J, Demetris AJ, Stieber AC, Marsh JW, Gordon RD, Esquivel CO, Iwatsuki S, Starzl TE. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? Transpl. Int. 1: 127-130 (1988).

• Leuschner M, Leuschner U, Lazarovici D, Kurtz W, Hellstern A. Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial. Gut 29: 428-432 (1988). *

• Levinson AI, Martin J. Rheumatoid factor: Dr. Jekyll or Mr. Hyde? Br. J. Rheumatol. 27: 83-87 (1988). *

• Lightdale CJ. Laparoscopy in the diagnosis of primary biliary cirrhosis: in the eye of the beholder. Hepatology 8: 190-191 (1988).

• Lillemoe KD, Pitt HA, Cameron JL. Sclerosing cholangitis. Adv. Surg. 21: 65-92 (1988).

• Lindor KD, Wiesner RH, Dickson ER, Homburger HA. The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes. Hepatology 8: 1555-1559 (1988).

• Liu CP, Bach FH, Wu SK. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. J. Immunol. 140: 3631-3639 (1988).

• Lozano F, Pares A, Borche L, Plana M, Gallart T, Rodes J, Vives J. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 8: 930-938 (1988).

• Lubbe N, Bornscheuer A, Grosse H, Ringe B, Gubernatis G, Seitz W. Changes in intraoperative total oxygen consumption in patients during liver transplantation. Anaesthesist 37: 211-217 (1988).

• Ludwig J. Etiology of biliary cirrhosis: diagnostic features and a new classification. Zentralbl. Allg. Pathol. 134: 132-141 (1988).

• Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J. Hepatol. 7: 193-199 (1988).

• MacDermott RP, Stenson WF. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv. Immunol. 42: 285-328 (1988).

• Maddrey WC. Primary biliary cirrhosis: new perspectives. Trans. Am. Clin. Climatol. Assoc. 100: 142-145 (1988).

• Maggiore G, De Giacomo C, Ugazio AG. Sclerosing cholangitis in childhood. Gastroenterology 94: 551-552 (1988).

• Manns M, Meyer zum Buschenfelde KH, Arnold W. The diagnostic value of immunologic findings in the differentiation of chronic liver diseases. Leber. Magen. Darm. 18: 290-292, 295, 298 (1988).

• Manns MP, Nakamura RM. Autoimmune liver diseases. Clin. Lab. Med. 8: 281-301 (1988).

• Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 8: 1662-1666 (1988).

• Mattei MG, Petkovich M, Mattei JF, Brand N, Chambon P. Mapping of the human retinoic acid receptor to the q21 band of chromosome 17. Hum. Genet. 80: 186-188 (1988).

• McCunney RJ. Diverse manifestations of trichloroethylene. Br. J. Ind. Med. 45: 122-126 (1988).

• McDonald J, Fam AG, Paton T, Senn J. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout. J. Rheumatol. 15: 865-868 (1988).

• McEvoy SM, Maeda N. Complex events in the evolution of the haptoglobin gene cluster in primates. J. Biol. Chem. 263: 15740-15747 (1988). *

• McIntyre PB, Rodrigues CA, Lennard-Jones JE, Barrison IG, Walker JG, Baron JH, Thornton PC. Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine. Aliment. Pharmacol. Ther. 2: 237-243 (1988).

• Meyer O. Immunogenetics in the understanding of multiple autoimmune syndromes. Ann. Med. Interne. (Paris) 139: 155-158 (1988).

• Meyers S, Sachar DB, Present DH, Janowitz HD. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand. J. Gastroenterol. Suppl. 148: 29-37 (1988).

• Mikhailidis DP, Fonseca V, Barradas MA, Hutton RA, Jeremy JY, Epstein O, McIntyre N, Dandona P. Platelet aggregation and thromboxane A2 release in primary biliary cirrhosis and effect of D-penicillamine treatment. Prostaglandins Leukot. Essent. Fatty Acids 31: 131-138 (1988).

• Minuk GY, Bohme CE, Burgess E, Hershfield NB, Kelly JK, Shaffer EA, Sutherland LR, Van Rosendaal G. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 95: 1356-1363 (1988).

• Miotti T, Bircher J, Preisig R. The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine. Digestion 39: 241-250 (1988).

• Misumi Y, Tashiro K, Hattori M, Sakaki Y, Ikehara Y. Primary structure of rat liver alkaline phosphatase deduced from its cDNA. Biochem. J. 249: 661-668 (1988). *

• Mitchison HC, Malcolm AJ, Bassendine MF, James OF. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 94: 463-470 (1988).

• Mizoguchi Y, Sakagami Y, Miyajima K, Yamamoto S, Morisawa S. Experimental immunological intrahepatic cholestasis model. Gastroenterol. Jpn. 23: 18-22 (1988).

• Momburg F, Koretz K, Von Herbay A, Moller P. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain - an immunohistological study on normal and chronically inflamed small intestine. Clin. Exp. Immunol. 72: 367-372 (1988). *

• Moreau X, Kunkel D, Carle JP, Swalduz B, Yao N. Primary sclerosing cholangitis: a larger spectrum? Gastroenterol. Clin. Biol. 12: 502-503 (1988).

• Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc. Natl. Acad. Sci. U.S.A. 85: 8111-8115 (1988). *

• Morel PA, Erlich HA, Fathman CG. A new look at the shared epitope hypothesis. Am. J. Med. 85: 20-22 (1988).

• Morgan G, Levinsky RJ. Clinical significance of IgA deficiency. Arch. Dis. Child. 63: 579-581 (1988). *

• Mu FT, Alderuccio F, Toh BH, Gershwin ME, Coppel R, Mackay IR. Murine monoclonal antibody to mitochondria reacts with the 72 kD antigen of primary biliary cirrhosis. Clin. Exp. Immunol. 71: 100-106 (1988). *

• Mulder CJ, Tytgat GN, Weterman IT, Dekker W, Blok P, Schrijver M, van der Heide H. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 95: 1449-1453 (1988).

• Nagasue N, Ogawa Y, Yukaya H, Tamada R, Chang Y, Nakamura T. Emergency distal splenorenal shunt for medically uncontrollable variceal haemorrhage. Zentralbl. Chir. 113: 446-454 (1988).

• Nagengast FM. Bile acids and colonic carcinogenesis. Scand. J. Gastroenterol. 23: 76-81 (1988).

• Nagura H, Sumi Y. Immunological functions of the gut - role of the mucosal immune system. Toxicol. Pathol. 16: 154-164 (1988).

• Nakajima T, Okino T, Okuyama S, Kaneko T, Yonekura I, Sato A. Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. Toxicol. Appl. Pharmacol. 94: 227-237 (1988).

• Nakanuma Y, Hoso M, Mizuno Y, Unoura M. Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice. Liver 8: 319-324 (1988).

• Nakanuma Y, Kato Y, Unoura M, Kobayashi K, Yamamoto M. An autopsy case of primary sclerosing cholangitis with sequential histologic observations of the liver. Acta Pathol. Jpn. 38: 249-257 (1988).

• Nakatani Y, Ogawa N, Sasaki Y, Yamada R, Misugi K. Pulmonary hypertension associated with portal hypertension in childhood. Case report of a 6-year-old child and review of the literature. Acta Pathol. Jpn. 38: 897-907 (1988).

• Nakayama H, Kobayashi M, Takahashi M, Ageishi Y, Takano T. Generalized eruption with severe liver dysfunction associated with occupational exposure to trichloroethylene. Contact Dermatitis 19: 48-51 (1988).

• Nelson RL, Tanure JC, Andrianopoulos G, Souza G, Lands WE. A comparison of dietary fish oil and corn oil in experimental colorectal carcinogenesis. Nutr. Cancer 11: 215-220 (1988).

• Nielsen OH, Ahnfelt-Ronne I. 4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl. Pharmacol. Toxicol. 62: 223-226 (1988).

• Nielsen OH, Verspaget HW, Elmgreen J. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid. Aliment. Pharmacol. Ther. 2: 203-211 (1988).

• Nikkila K, Miettinen TA. Serum cholesterol precursors, cholestanol, and plant sterols in primary biliary cirrhosis. Scand. J. Gastroenterol. 23: 967-972 (1988).

• Nikolovska D, Dzhadzhova-Boneva M, Bakalov V, Kadiian Kh. Changes in the liver of patients with chronic ulcerohemorrhagic colitis. Vutr. Boles. 27: 6-9 (1988).

• Nilsson K, Dahlgren UI, Hanson LA. Different origins of IgA antibodies with various antigen specificities appearing in rat bile. Scand. J. Immunol. 28: 547-551 (1988).

• No authors listed. Abnormal liver function tests in a middle-aged woman. J. Tenn. Med. Assoc. 81: 40 (1988).

• No authors listed. Sulfasalazine inhibits folate absorption. Nutr. Rev. 46: 320-323 (1988).

• Noda M, Yoon K, Prince CW, Butler WT, Rodan GA. Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. J. Biol. Chem. 263: 13916-13921 (1988). *

• Nyberg A, Berne B, Nordlinder H, Busch C, Eriksson U, Loof L, Vahlquist A. Impaired release of vitamin A from liver in primary biliary cirrhosis. Hepatology 8: 136-141 (1988).

• Nyberg A, Engstrom-Laurent A, Loof L. Serum hyaluronate in primary biliary cirrhosis- a biochemical marker for progressive liver damage. Hepatology 8: 142-146 (1988).

• Oates E, Sarno RC. Sharp bone marrow uptake of indium-111 leukocytes in a splenectomized patient with sclerosing cholangitis. Clin. Nucl. Med. 13: 623-624 (1988).

• Okabe N, Matsuoka Y, Ueda I, Fujita K, Mashiba H, Matsunaga K, Yao T. Immunological studies on Crohn's disease. VII. Reduced immunologic activity in monocytes. J. Clin. Lab. Immunol. 25: 69-72 (1988).

• Ollier W, Thomson W, Welch S, de Lange GG, Silman A. Chromosome 14 markers in rheumatoid arthritis. Ann. Rheum. Dis. 47: 843-848 (1988). *

• Olomu AB, Vickers CR, Waring RH, Clements D, Babbs C, Warnes TW, Elias E. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis. N. Engl. J. Med. 318: 1089-1092 (1988).

• Owerbach D, Gunn S, Ty G, Wible L, Gabbay KH. Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31: 751-757 (1988).

• Ozawa A, Ohkido M, Inoko H, Ando A, Tsuji K. Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 90: 402-405 (1988).

• Pain JA, Bailey ME. Prevention of endotoxaemia in obstructive jaundice - a comparative study of bile salts. HPB Surg. 1: 21-27 (1988). *

• Pallone F, Fais S, Capobianchi MR. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin. Exp. Immunol. 74: 75-79 (1988). *

• Pares A, Grande L, Bruix J, Pera C, Rodes J. Esophageal dysfunction in primary biliary cirrhosis. J. Hepatol. 7: 362-367 (1988).

• Pashchenko IG, Romanov AA, Zhumanbaeva RM, Osmolovskii VS, Faliushina NV. Comprehensive characteristics of the pulmonary syndrome in chronic liver diseases. Ter. Arkh. 60: 102-105 (1988).

• Persson PG, Ahlbom A. Relative risk is a relevant measure of association of left-handedness with inflammatory bowel disease. Neuropsychologia 26: 737-740 (1988).

• Pironi L, Cornia GL, Ursitti MA, Dallasta MA, Miniero R, Fasano F, Miglioli M, Barbara L. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine. Int. J. Clin. Pharmacol. Res. 8: 143-148 (1988).

• Pirovino M, Jeanneret C, Lang RH, Luisier J, Bianchi L, Spichtin H. Liver cirrhosis in histiocytosis X. Liver 8: 293-298 (1988).

• Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, Zuin M. Ursodeoxycholic acid for chronic liver diseases. J. Clin. Gastroenterol. 10 Suppl. 2: S25-S31 (1988).

• Podymova SD, Budanov SV. Primary sclerosing cholangitis. Ter. Arkh. 60: 139-141 (1988).

• Pomier-Layrargues G, Huet PM, Infante-Rivard C, Villeneuve JP, Marleau D, Duguay L, Tanguay S, Lavoie P. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt. Hepatology 8: 1506-1510 (1988).

• Pooler PA, Duane WC. Effects of bile acid administration on bile acid synthesis and its circadian rhythm in man. Hepatology 8: 1140-1146 (1988).

• Popova NV, Popov MS, Sekamova SM, Krel' PE. Morphogenesis of primary biliary liver cirrhosis. Arkh. Patol. 50: 19-24 (1988).

• Porto MH, Birroli MI, Duarte AJ, Carneiro-Sampaio MM. Peripheral lymphocyte subpopulations in selective IgA deficiency. Rev. Hosp. Clin. Fac. Med. Sao Paulo 43: 294-297 (1988).

• Poulsen LO, Freund L, Lylloff K, Grunnet N. Positive Coombs' test associated with ulcerative colitis. A prevalence study. Acta Med. Scand. 223: 75-78 (1988).

• Qin OY, el-Youssef M, Yen-Lieberman B, Sapatnekar W, Youngman KR, Kusugami K, Fiocchi C. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig. Dis. Sci. 33: 1528-1536 (1988).

• Rager-Zisman B. Virus-induced autoimmunity. Isr. J. Med. Sci. 24: 363-365 (1988).

• Rasmussen R, Takatsu K, Harada N, Takahashi T, Bottomly K. T cell-dependent hapten-specific and polyclonal B cell responses require release of interleukin 5. J. Immunol. 140: 705-712 (1988).

• Raymond JZ, Goldman HM. An unusual cutaneous reaction secondary to allopurinol. Cutis 41: 323-326 (1988).

• Raziuddin S, Danial BH. OKT4+ T cell deficiency and an association of immunoglobulin deficiency in systemic lupus erythematosus. Clin. Exp. Immunol. 72: 446-449 (1988). *

• Rees RC, Buckle AM, Gelsthorpe K, James V, Potter CW, Rogers K, Jacob G. Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br. J. Cancer 57: 374-377 (1988).

• Regueiro JR, Arnaiz-Villena A. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population. Tissue Antigens 31: 14-25 (1988).

• Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig. Dis. Sci. 33: 1601-1614 (1988).

• Renner EL, Lake JR, Cragoe EJ Jr, Van Dyke RW, Scharschmidt BF. Ursodeoxycholic acid choleresis: relationship to biliary HCO3- and effects of Na+-H+ exchange inhibitors. Am. J. Physiol. 254: G232-G241 (1988).

• Rifle G, Mousson C, Hillon P, Marceau M, Chalopin JM, Tanter Y. Primary biliary cirrhosis: therapeutic trial using plasma exchange and immunosuppression. Preliminary results. Ann. Med. Interne (Paris) 139 Suppl. 1: 32-34 (1988).

• Rigby WF. The immunobiology of vitamin D. Immunol. Today 9: 54-58 (1988).

• Rijk MC, van Schaik A, van Tongeren JH. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds. Scand. J. Gastroenterol. Suppl. 148: 54-59 (1988).

• Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 29: 669-674 (1988). *

• Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 94: 1383-1389 (1988).

• Roda A, Grigolo B, Roda E, Simoni P, Pellicciari R, Natalini B, Fini A, Labate AM. Quantitative relationship between bile acid structure and biliary lipid secretion in rats. J. Pharm. Sci. 77: 596-605 (1988).

• Roediger WE. What sequence of pathogenetic events leads to acute ulcerative colitis? Dis. Colon Rectum 31: 482-487 (1988).

• Roenigk HH Jr. Liver toxicity of retinoid therapy. J. Am. Acad. Dermatol. 19: 199-208 (1988).

• Roep BO, Bontrop RE, Pena AS, van Eggermond MC, van Rood JJ, Giphart MJ. An HLA-DQ alpha allele identified at DNA and protein level is strongly associated with celiac disease. Hum. Immunol. 23: 271-279 (1988).

• Rosch T, Dancygier H. Primary sclerosing cholangitis. Leber. Magen. Darm. 18: 184-196 (1988).

• Rossini AA, Mordes JP, Handler ES. Speculations on etiology of diabetes mellitus. Tumbler hypothesis. Diabetes 37: 257-261 (1988). *

• Rutgers HC, Stradley RP, Johnson SE. Serum bile acid analysis in dogs with experimentally induced cholestatic jaundice. Am. J. Vet. Res. 49: 317-320 (1988).

• Saitoh S, Yamada S, Takagi H, Abe T, Takezawa J, Nagamine T, Kobayashi S, Iizuka H, Katakai S. A male autopsy case of primary biliary cirrhosis associated with polymyositis and congestive cardiomyopathy. Nippon Shokakibyo Gakkai Zasshi 85: 287-291 (1988).

• Saitoh T, Fujiwara M, Nomoto M, Makino M, Watanabe H, Ishihara K, Kamimura T, Ichida F. Hepatic lesions induced by graft-versus-host reaction across MHC class II antigens: an implication for animal model of primary biliary cirrhosis. Clin. Immunol. Immunopathol. 49: 166-172 (1988).

• Saji Y. The effect of decreased portal blood flow on the biliary system. Jpn. J. Surg. 18: 558-568 (1988).

• Sakkas LI, Demaine AG, Panayi GS, Welsh KI. Arthritis in patients with psoriasis is associated with an immunoglobulin gene polymorphism. Arthritis Rheum. 31: 276-278 (1988).

• Samuel D, Sattouf E, Degott C, Benhamou JP. Cirrhosis and biliary lithiasis in France: a postmortem study. Gastroenterol. Clin. Biol. 12: 39-42 (1988).

• Sanderson F, Quaranta JF, Cassuto-Viguier E, Grimaldi C, Troin D, Dujardin P, Delmont J. The value of plasma exchange during flare-ups of benign recurrent intrahepatic cholestasis. Ann. Med. Interne (Paris) 139 Suppl. 1: 35-37 (1988).

• Saunders D, Sillery J, Chapman R. Effect of calcium carbonate and aluminum hydroxide on human intestinal function. Dig. Dis. Sci. 33: 409-413 (1988).

• Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. U.S.A. 85: 3504-3508 (1988). *

• Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am. J. Gastroenterol. 83: 216-223 (1988).

• Schteingart CD, Hofmann AF. Synthesis of 24-nor-5 beta-cholan-23-oic acid derivatives: a convenient and efficient one-carbon degradation of the side chain of natural bile acids. J. Lipid Res. 29: 1387-1395 (1988). *

• Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: a review. J. Am. Acad. Dermatol. 18: 559-568 (1988).

• Schwimmbeck PL, Oldstone MB. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies. Am. J. Med. 85: 51-53 (1988).

• Sela D, Goshen A, Shoenfeld Y. The clinical significance of IgA deficiency. Harefuah. 114: 560-563 (1988).

• Seldenrijk CA, Hendriks G, Smeulders AW, Baak JP, van Spreeuwel JP, Meuwissen SG, Meijer CJ. Reproducibility of counting immunoglobulin-containing cells in colonic mucosal biopsies. Anal. Quant. Cytol. Histol. 10: 94-100 (1988).

• Shelley ED, Shelley WB. Cyclosporine therapy for pyoderma gangrenosum associated with sclerosing cholangitis and ulcerative colitis. J. Am. Acad. Dermatol. 18: 1084-1088 (1988).

• Shepherd NA, Hall PA, Coates PJ, Levison DA. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology 12: 235-252 (1988).

• Sherman S, Nieland NS, Van Thiel DH. Sarcoidosis and primary biliary cirrhosis. Coexistence in a single patient. Dig. Dis. Sci. 33: 368-374 (1988).

• Sherr E, Adelman DC, Saxon A, Gilly M, Wall R, Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. J. Exp. Med. 168: 55-71 (1988). *

• Shibata J, Murata H, Fujiyama S, Yoshida K, Sato T. A case of primary biliary cirrhosis treated with colchicine and ursodeoxycholic acid. Nippon Shokakibyo Gakkai Zasshi 85: 2265-2269 (1988).

• Shiomi S, Kuroki T, Kurai O, Kobayashi K, Ikeoka N, Monna T, Ochi H. Portal circulation by technetium-99m pertechnetate per-rectal portal scintigraphy. J. Nucl. Med. 29: 460-465 (1988).

• Silman A, Ollier B, McDermott M. HLA: linkage with rheumatoid arthritis or seropositivity. J. Rheumatol. 15: 1189-1192 (1988).

• Sorensen RU, Kallick MD. Clinical uses of intravenous immune globulin: immunoglobulin replacement therapy and treatment of autoimmune cytopenias. J. Clin. Apher. 4: 97-103 (1988).

• Spengler U, Pape GR, Hoffmann RM, Johnson JP, Eisenburg J, Paumgartner G, Riethmuller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology 8: 459-462 (1988).

• Stemerowicz R, Hopf U, Moller B, Wittenbrink C, Rodloff A, Reinhardt R, Freudenberg M, Galanos C. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of Enterobacteriaceae? Lancet 2: 1166-1170 (1988).

• Stenson WF, MacDermott RP. Immunology of inflammatory bowel disease. Year Immunol. 3: 310-322 (1988).

• Sterkers G, Zeliszewski D, Chaussee AM, Deschamps I, Font MP, Freidel C, Hors J, Betuel H, Dausset J, Levy JP. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc. Natl. Acad. Sci. U.S.A. 85: 6473-6477 (1988). *

• Stiehl A, Raedsch R, Rudolph G. Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment. Gastroenterology 94: 1201-1206 (1988).

• Stockbrugger RW, Olsson R, Jaup B, Jensen J. Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology 35: 289-294 (1988).

• Strandvik B, Bronnegard M, Gilljam H, Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand. J. Gastroenterol. Suppl. 143: 1-4 (1988). *

• Strandvik B, Hjelte L, Gabrielsson N, Glaumann H. Sclerosing cholangitis in cystic fibrosis. Scand. J. Gastroenterol. Suppl. 143: 121-124 (1988). *

• Sugiura H, Hayashi M, Koshida R, Watanabe R, Nakanuma Y, Ohta G. Nonsyndromatic paucity of intrahepatic bile ducts in congenital syphilis. A case report. Acta Pathol. Jpn. 38: 1061-1068 (1988).

• Sundewall AC, Lefvert K. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease. Ann. N. Y. Acad. Sci. 540: 525-527 (1988). *

• Surh CD, Cooper AE, Coppel RL, Leung P, Ahmed A, Dickson R, Gershwin ME. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology 8: 290-295 (1988).

• Suzuki T, Okada J, Kashiwazaki S. Selective IgA deficiency developed during treatment of scleroderma kidney with captopril. J. Rheumatol. 15: 716-717 (1988).

• Swain SL, McKenzie DT, Weinberg AD, Hancock W. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J. Immunol. 141: 3445-3455 (1988).

• Swarovsky B, Schwerk WB, Arnold R. Secondary biliary liver cirrhosis and exocrine pancreatic insufficiency in stenosis of Vater's ampulla. Med. Klin. (Munich) 83: 100-106 (1988).

• Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N. Low serum creatinine levels in severe hepatic disease. Arch. Intern. Med. 148: 1313-1315 (1988).

• Thompson GN, Davidson GP. In vivo bile acid uptake from terminal ileum in cystic fibrosis. Pediatr. Res. 23: 323-328 (1988).

• Thompson JN, Cohen J, Moore RH, Blenkharn JI, McConnell JS, Matkin J, Blumgart LH. Endotoxemia in obstructive jaundice. Observations on cause and clinical significance. Am. J. Surg. 155: 314-321 (1988).

• Thompson JS, Burnett DA, Markin RS, Vaughan WP. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease. Am. J. Gastroenterol. 83: 756-760 (1988).

• Thomsen M, Molvig J, Zerbib A, de Preval C, Abbal M, Dugoujon JM, Ohayon E, Svejgaard A, Cambon-Thomsen A, Nerup J. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes. Immunogenetics 28: 320-327 (1988).

• Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 297: 1501-1504 (1988). *

• Tiercy JM, Gorski J, Jeannet M, Mach B. Identification and distribution of three serologically undetected alleles of HLA-DR by oligonucleotide.DNA typing analysis. Proc. Natl. Acad. Sci. U.S.A. 85: 198-202 (1988). *

• Treem WR, Rusnack EJ, Ragsdale BD, Seikaly MG, DiPalma JS. Inflammatory bowel disease in a patient with nephropathic cystinosis. Pediatrics 81: 584-587 (1988).

• Truelove SC. Evolution of olsalazine. Scand. J. Gastroenterol. Suppl. 148: 3-6 (1988).

• Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29: 990-996 (1988). *

• Uddenfeldt P, Bjerle P, Danielsson A, Nystrom L, Stjernberg N. Lung function abnormalities in patients with primary biliary cirrhosis. Acta Med. Scand. 223: 549-555 (1988).

• Ueda Y, Araki K, Matsumoto M, Okanoue T, Takino T. A case of polymyositis associated with asymptomatic primary biliary cirrhosis. Nippon Naika Gakkai Zasshi 77: 115-116 (1988).

• Van de Water J, Fregeau D, Davis P, Ansari A, Danner D, Leung P, Coppel R, Gershwin ME. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J. Immunol. 141: 2321-2324 (1988).

• Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J. Exp. Med. 167: 1791-1799 (1988). *

• van Zanten RA, van Leeuwen RE, Wilson JH. Serum procollagen III N-terminal peptide and laminin P1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis. Clin. Chim. Acta 177: 141-146 (1988).

• Verresen L, Waer M, Verberckmoes R, Morias P, Michielsen P. Primary sclerosing cholangitis associated with membranous nephropathy. Ann. Intern. Med. 108: 909-910 (1988).

• Vettin L, Rohrer MD, Young SK, Reichart P. Oral manifestations of Crohn's disease. Dtsch. Z. Mund. Kiefer. Gesichtschir. 12: 473-476 (1988).

• Wall WJ, Grant DR, Ghent CN, Sommerauer JF, Mimeault RM, Girvan DP, Stiller CR, Duff JH. Liver transplantation: the University Hospital-Children's Hospital of Western Ontario experience. Clin. Transpl. 1988: 45-51 (1988).

• Walt RP, Daneshmend TK, Fellows IW, Toghill PJ. Effect of stanozolol on itching in primary biliary cirrhosis. Br. Med. J. (Clin. Res. Ed.) 296: 607 (1988).

• Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology 8: 1679-1683 (1988).

• Wanless IR. Understanding noncirrhotic portal hypertension: menage a fois. Hepatology 8: 192-193 (1988).

• Warner HB, Carp RI. Multiple sclerosis etiology - an Epstein-Barr virus hypothesis. Med. Hypotheses 25: 93-97 (1988).

• Watkins DI, Hodi FS, Letvin NL. A primate species with limited major histocompatibility complex class I polymorphism. Proc. Natl. Acad. Sci. U.S.A. 85: 7714-7718 (1988). *

• Weber M, Lohse AW, Manns M, Meyer zum Buschenfelde KH, Kohler H. IgG subclass distribution of autoantibodies to glomerular basement membrane in Goodpasture's syndrome compared to other autoantibodies. Nephron 49: 54-57 (1988).

• Weetman AP, Roe C, So A. DX alpha gene polymorphism in Graves' disease. Tissue Antigens 31: 1-4 (1988).

• Weill BJ, Menkes CJ, Cormier C, Louvel A, Dougados M, Houssin D. Hepatocellular carcinoma after danazol therapy. J. Rheumatol. 15: 1447-1449 (1988).

• Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 95: 130-136 (1988).

• Wiedmann KH, Weber P, Lauchart W. What is safe in therapy of primary biliary cirrhosis? Internist (Berl.) 29: 765-777 (1988).

• Wiesner RH, Grambsch P, LaRusso NF, Dickson ER. Is primary sclerosing cholangitis a progressive disease or not? Hepatology 8: 970-972 (1988).

• Wiesner RH, Grambsch PM, Lindor KD, Ludwig J, Dickson ER. Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis. Hepatology 8: 668-676 (1988).

• Willoughby CP, Cowan RE, Gould SR, Machell RJ, Stewart JB. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis. Scand. J. Gastroenterol. Suppl. 148: 40-44 (1988).

• Wise RA, Wigley FM, Scott TE, Hochberg MC. HLA-DQw alloantigens and pulmonary dysfunction in rheumatoid arthritis. Chest 94: 609-614 (1988).

• Wolf A, Gaedicke G, Leupold D, Kohne E. Treatment of Crohn disease with intravenous immunoglobulin. Monatsschr. Kinderheilkd. 136: 101-103 (1988).

• Wolf R, Krakowski A. Variations in aquagenic pruritus and treatment alternatives. J. Am. Acad. Dermatol. 18: 1081-1083 (1988).

• Wood JR, Taswell HF, Czaja AJ, Rabe D. Pattern and duration of HBV DNA seropositivity in acute hepatitis B. Dig. Dis. Sci. 33: 477-480 (1988).

• Yamada H, Shimizu H, Taniguchi O, Okumura K. Leu-1(CD5) B cell subpopulation in patients with various liver diseases - special reference to hepatitis B virus carrier and to changes caused by prednisolone therapy. Int. Arch. Allergy Appl. Immunol. 87: 409-416 (1988).

• Yamagiwa I, Iwafuchi M, Ohsawa Y, Yagi M, Iinuma Y, Narisawa R. A case report of intrahepatic biliary atresia showing an unusual liver histology. Jpn. J. Surg. 18: 213-217 (1988).

• Yeaman SJ, Fussey SP, Danner DJ, James OF, Mutimer DJ, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1: 1067-1070 (1988).

• Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc. Natl. Acad. Sci. U.S.A. 85: 8256-8260 (1988). *

• Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW. Increased intestinal permeability associated with infection in burn patients. Arch. Surg. 123: 1313-1319 (1988).

Number of references = 345

www psc-literature.org